Albumin, as an exogenous or endogenous carrier protein for treating various diseases—primarily cancer [15], rheumatoid arthritis, diabetes and hepatitis—has demonstrated its potential in the form of products and numerous clinical trials [16]. The gene discussed is ALB; the disease is diabetes mellitus.